Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more
Entero Healthcare Solutions Ltd. - Asset Resilience Ratio
Entero Healthcare Solutions Ltd. (ENTERO) has an Asset Resilience Ratio of 9.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Entero Healthcare Solutions Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Entero Healthcare Solutions Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0% |
| Short-term Investments | ₹2.73 Billion | 9.58% |
| Total Liquid Assets | ₹2.73 Billion | 9.58% |
Asset Resilience Insights
- Limited Liquidity: Entero Healthcare Solutions Ltd. maintains only 9.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Entero Healthcare Solutions Ltd. Industry Peers by Asset Resilience Ratio
Compare Entero Healthcare Solutions Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Entero Healthcare Solutions Ltd. (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Entero Healthcare Solutions Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 2.13% | ₹575.55 Million | ₹27.03 Billion | -29.54pp |
| 2023-09-30 | 31.67% | ₹7.43 Billion | ₹23.45 Billion | +25.87pp |
| 2022-09-30 | 5.80% | ₹814.82 Million | ₹14.04 Billion | +0.57pp |
| 2021-09-30 | 5.23% | ₹588.90 Million | ₹11.26 Billion | -0.83pp |
| 2020-09-30 | 6.06% | ₹505.10 Million | ₹8.34 Billion | +2.37pp |
| 2019-09-30 | 3.69% | ₹276.62 Million | ₹7.49 Billion | -- |